T. Michael Numnum - Concepedia

Author

T. Michael Numnum

Also Known As

T Michael Numnum, T NUMNUM, T. M. Numnum, T. Michael Numnum, T. Numnum, T.M. NUMNUM, T.M. Numnum, T.Michael Numnum, Thomas M. Numnum

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham Washington University in St. Louis Heinrich Heine University Düsseldorf Louisiana State University Health Sciences Center Shreveport

About

T. Michael Numnum is an author at University of Alabama at Birmingham specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	898
2	Health Sciences	2	2	227
3	Engineering	1	1	129
4	Public Health	1	1	22
5	Biomedical Engineering	1	1	129

T. Michael Numnum

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma Mariam A. Stoff‐Khalili, Ángel A. Rivera, J. Michael Mathis, Breast Cancer Research and Treatment Regenerative MedicineMesenchymal Stem CellsCell-based Drug DeliveryTargeted DeliveryMedicine	2007	205
Conservative Management of Stage I Endometrial Carcinoma after Surgical Staging J. Michael Straughn, Warner K. Huh, FJ Kelly, Gynecologic Oncology Surgical OncologyGynecological SurgeryMedicineGynecologySurgery	2002	146
Promotion of incisional wound repair by human mesenchymal stem cell transplantation Alexander Stoff, Ángel A. Rivera, N. Sanjib Banerjee, Experimental Dermatology Tissue EngineeringCell TherapyEngineeringAdult Stem CellImmunology	2008	129
The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma T. Michael Numnum, Rodney P. Rocconi, Jenny M. Whitworth, Gynecologic Oncology Symptomatic AscitesOncologyRefractory Ovarian CarcinomaCancer ManagementPathology	2006	125
A Prospective Evaluation of "See and Treat" in Women with HSIL Pap Smear Results: Is This an Appropriate Strategy? T. Michael Numnum, Tyler O. Kirby, Charles A. Leath, Journal of Lower Genital Tract Disease	2005	56
Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy Tyler O. Kirby, Rodney P. Rocconi, T. Michael Numnum, Gynecologic Oncology Surgical OncologyVulvar DiseasesGynecological SurgeryMinimally Invasive ProcedureGynecology	2005	55
The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study Gregory Sfakianos, T. Michael Numnum, Caitlin B. Halverson, Gynecologic Oncology Retrospective Cohort StudyGastrointestinal OncologyMedicineCancer ManagementGastroenterology	2009	48
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma Kristopher J. Kimball, T. Michael Numnum, Tyler O. Kirby, Gynecologic Oncology MedicineGynecologyCancer TreatmentOncologyRadiation Oncology	2008	44
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer Jason D. Wright, Angeles Alvarez Secord, T. Michael Numnum, International Journal of Gynecological Cancer	2007	44
Patterns of Failure for Conservatively Managed Surgical Stage I Uterine Carcinosarcoma Charles A. Leath, T. Michael Numnum, James E. Kendrick, International Journal of Gynecological Cancer	2009	38

Page 1